In an era of high-tech diagnostics and billion-dollar biotech, the return of syphilis—an infection many assumed long subdued—feels both archaic and alarming.
On May 13, 2025, the U.S. Preventive Services Task Force (USPSTF) released its updated recommendation reaffirming the need for universal syphilis screening in all pregnant individuals during their first prenatal visit. While the rating—Grade A—was consistent with previous guidance, the reaffirmation comes amid a steep and troubling rise in congenital syphilis cases across the United States.
This reaffirmation, though seemingly routine, is neither ceremonial nor redundant. In fact, it may be one of the most consequential acts of preventative policy in reproductive medicine today. The stakes are high: syphilis is entirely preventable and treatable, but if left undiagnosed during pregnancy, it can cause stillbirth, miscarriage, preterm labor, and lifelong disability in newborns.
As the announcement circulated among medical journals and public health networks, an unlikely amplification force emerged: OB-GYN TikTok creators, who launched an urgent wave of explainers, pregnancy Q&A sessions, and myth-busting videos under the banner of #SyphilisScreening—a hashtag that saw a 700% increase in engagement within 72 hours of the USPSTF’s announcement.
The Rising Tide of a “Historical” Infection
To understand the weight of this policy reaffirmation, one must first confront the numbers.
According to the Centers for Disease Control and Prevention (CDC), congenital syphilis cases in the U.S. have increased by more than 900% since 2012, with over 3,700 cases reported in 2023 alone—the highest since the 1940s (CDC Surveillance Report). The rise has been particularly steep in Southern states, Native American communities, and among Black and Hispanic populations, where access to early prenatal care is often limited.
This is not simply a rural problem or a reflection of poor personal choices. It is the result of systemic healthcare fragmentation, inadequate STI funding, and rising social vulnerabilities—from substance use disorder to housing instability. “Syphilis thrives where care falters,” said Dr. Angela Nardone, a maternal-fetal medicine specialist in New Orleans.
USPSTF Reaffirmation: What It Means—and Doesn’t
The USPSTF reaffirmed its Grade A recommendation, which mandates that all pregnant people undergo syphilis testing at their first prenatal appointment. Under the Affordable Care Act, such Grade A recommendations must be covered without cost-sharing, ensuring that testing remains universally accessible and covered by both public and private insurers.
But reaffirmation is not routine when the context is shifting rapidly. The USPSTF is effectively re-drawing attention to an old standard in a new crisis—placing a bright spotlight on both clinical diligence and public health gaps. Notably, the task force emphasized that:
- Testing must occur early in pregnancy, ideally before 12 weeks gestation.
- Repeat screening is recommended in the third trimester for those at high risk (e.g., patients with multiple partners, drug use history, or unstable housing).
- Penicillin G remains the only approved treatment for preventing congenital transmission—highlighting the need for timely identification and adherence.
Critically, the recommendation avoids additional screening mandates later in pregnancy unless risk factors are documented—a point that some practitioners argue is insufficient in an era of rising incidence.
The TikTok Effect: How #OBGYN Creators Are Driving Clinical Awareness
Perhaps most surprising—and effective—was how the USPSTF reaffirmation jumped from policy brief to algorithmic trend. OB-GYN creators like @DrLauraDelivers, @MamaDocMed, and @PrenatalPearls posted short videos explaining the importance of screening, demystifying the process, and walking patients through what to expect at their first prenatal visit.
In a post viewed over 1.2 million times, @DrLauraDelivers looks into the camera and says, “If you’re pregnant and your provider hasn’t talked to you about syphilis screening, ask. It’s not awkward. It’s lifesaving.”
Such content has proven powerful. Studies show that medical professionals on social media are now one of the most trusted sources of health information among Gen Z and millennial patients, especially when discussing reproductive and sexual health (Pew Research Center).
As more patients encounter #SyphilisScreening in their feeds, clinicians are reporting increased rates of informed consent and earlier engagement in prenatal STI testing.
Why This Matters Now: Systemic Strain and Public Health Lag
The recommitment to universal screening lands in a constrained and politically charged landscape.
- Public health departments remain underfunded, with many STI clinics operating at reduced hours or shuttering altogether.
- OB-GYN shortages, particularly in rural areas and across 26 states with recent abortion bans, have made it harder to secure timely prenatal appointments.
- Stigma around STIs in pregnancy still looms large, dissuading patients from disclosing risk factors or consenting to tests—even when offered.
Additionally, the syphilis resurgence is tightly intertwined with the opioid epidemic, as increased rates of transactional sex and needle-sharing behaviors correlate with spikes in infection among pregnant people. Without a robust safety net—including housing, addiction treatment, and trauma-informed care—testing alone will not reverse the trend.
“Screening is the floor, not the ceiling,” said Dr. Sophia Kim, Director of Perinatal Infectious Disease at UCSF. “We have to be asking what happens after the positive result.”
The Clinical Realities: Preventable Harm, Lasting Impact
Syphilis during pregnancy can be asymptomatic or mistaken for benign conditions, but its consequences are profound.
Congenital syphilis, transmitted from mother to fetus, can cause:
- Stillbirth or neonatal death
- Severe anemia and jaundice
- Facial and skeletal deformities
- Blindness, deafness, or neurological damage
Yet, 95% of these outcomes can be prevented with timely detection and penicillin treatment, ideally before the second trimester. This makes the current resurgence all the more infuriating—it’s not an issue of therapeutic limitation, but of clinical inattention and systemic neglect.
A 2024 review in The Lancet called congenital syphilis “the most solvable maternal-fetal health crisis in modern medicine.”
Toward a Smarter Future: Surveillance, Equity, and Trust
Looking ahead, several strategies could help transform this reaffirmation into true reversal:
- Expanded point-of-care testing in community clinics, mobile units, and pharmacies
- Bundling STI screening with early ultrasound visits to reduce missed opportunities
- Culturally tailored public health campaigns addressing stigma in high-incidence communities
- More aggressive third-trimester rescreening protocols, especially in jurisdictions with elevated maternal STI rates
But perhaps the most urgent shift lies in rebuilding trust between healthcare systems and the populations most at risk. That trust is not built through mandates or press releases, but through continuity, empathy, and culturally literate care.
Final Thought: An Old Threat, A New Mandate
The return of syphilis in pregnancy is not a failure of science—it is a failure of systems. The USPSTF reaffirmation is not a new discovery—it is a recommitment to a truth we never should have stopped acting on.
In 2025, we are again reminded that simple, evidence-based screening protocols can save lives—but only if they are implemented early, equitably, and without shame.
The hashtag may fade, but the stakes will not.
